Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q3 2023 · 10-Q
Revenue$6.12M$6.12M−28.8% vs Q3 2022 Net Income-$1.77M-$1.77MN/M vs Q3 2022 EPS Diluted-$1.16-$1.16N/M vs Q3 2022 Gross Profit$3,845,541−35.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$240,573N/M Free Cash Flowderived-$342,962N/M Margins · derivedGross margin62.8%−6.2 pt vs Q3 2022
Operating margin-29.8%+355.7 pt vs Q3 2022
Net margin-28.9%+339.2 pt vs Q3 2022
ended Jun 30, 2023 · filed Aug 10, 2023 · 41 d after period end